Cite
The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.
MLA
Hillen, Maarten R., et al. “The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.” PloS One, vol. 10, no. 6, June 2015, p. e0130830. EBSCOhost, https://doi.org/10.1371/journal.pone.0130830.
APA
Hillen, M. R., Hartgring, S. A. Y., Willis, C. R., Radstake, T. R. D. J., Hack, C. E., Lafeber, F. P. J. G., & van Roon, J. A. G. (2015). The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade. PloS One, 10(6), e0130830. https://doi.org/10.1371/journal.pone.0130830
Chicago
Hillen, Maarten R, Sarita A Y Hartgring, Cynthia R Willis, Timothy R D J Radstake, Cornelis E Hack, Floris P J G Lafeber, and Joel A G van Roon. 2015. “The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.” PloS One 10 (6): e0130830. doi:10.1371/journal.pone.0130830.